Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Lucia Martiniova"'
Autor:
Lucia Martiniova, Serageldin Kamel, Kalevi Kairemo, Robert Benjamin, Neeta Somaiah, Gregory Ravizzini, Elise F. Nassif Haddad
Publikováno v:
Diagnostics, Vol 14, Iss 18, p 2021 (2024)
The purpose of this study was to evaluate the predictive features of baseline F-18-fluorodeoxy-D-glucose positron emission tomography (18F-FDG PET)/computed tomography (CT) parameters in patients with dedifferentiated liposarcomas (DDLPSs) and well-d
Externí odkaz:
https://doaj.org/article/17555ae517f143e8a13f134c52206c6b
Autor:
Serageldin Kamel, Lucia Martiniova, Eslam Aboismail, Joo Schmidt, Sairah Ahmed, Ranjit Nair, Raphael E. Steiner, Michael L. Wang, Sarita Soebianto, Gregory Ravizzini, Tinsu Pan, Hun Ju Lee
Publikováno v:
HemaSphere, Vol 6, Pp 48-48 (2022)
Externí odkaz:
https://doaj.org/article/070e805b624c45f8b9d902d722549360
Autor:
Stephanie M J Fliedner, Nina Kaludercic, Xiao-Sheng Jiang, Hana Hansikova, Zuzana Hajkova, Jana Sladkova, Andrea Limpuangthip, Peter S Backlund, Robert Wesley, Lucia Martiniova, Ivana Jochmanova, Nikoletta K Lendvai, Jan Breza, Alfred L Yergey, Nazareno Paolocci, Arthur S Tischler, Jiri Zeman, Forbes D Porter, Hendrik Lehnert, Karel Pacak
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40949 (2012)
A glycolytic profile unifies a group of pheochromocytomas and paragangliomas (PHEOs/PGLs) with distinct underlying gene defects, including von Hippel-Lindau (VHL) and succinate dehydrogenase B (SDHB) mutations. Nevertheless, their tumor aggressivenes
Externí odkaz:
https://doaj.org/article/844067b0e35e427194db189b9be25cdb
Autor:
Lucia Martiniova, Jie Lu, Jeffrey Chiang, Marcelino Bernardo, Russell Lonser, Zhengping Zhuang, Karel Pacak
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e14678 (2011)
The failure of cytotoxic cancer regimens to cure the most drug-resistant, well-differentiated solid tumors has been attributed to the heterogeneity of cell types that differ in their capacities for growth, differentiation, and metastases. We investig
Externí odkaz:
https://doaj.org/article/695472c1f56547788600fd2d1cd1f326
Publikováno v:
Cancer journal (Sudbury, Mass.). 28(6)
Antibody-drug conjugates (ADCs) are designed to deliver cytotoxic payloads to distinctive target-expressing cancer cells. Following internalization, the ADCs are routed to different compartments in the cells, where cleavage of the linker causes relea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fdf6b56cac3e09455cf7fff3208bb73
https://pubmed.ncbi.nlm.nih.gov/36383907
https://pubmed.ncbi.nlm.nih.gov/36383907
Autor:
Lucia Martiniova, Ryan Bitar, Lisly J. Chery, Gregory Ravizzini, Amado J. Zurita, Janio Szklaruk
Publikováno v:
Clinical Nuclear Medicine. 46:e3-e5
A 60-year-old man with prostate adenocarcinoma status post radical prostatectomy and bilateral pelvic lymph node dissection referred for restaging F-fluciclovine PET/CT due to rising serum prostate-specific antigen levels (1.1 ng/mL at that time of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab1a5a8a2a296277bef7ce40d21745b2
https://doi.org/10.1097/rlu.0000000000003272
https://doi.org/10.1097/rlu.0000000000003272
Publikováno v:
Clinical Nuclear Medicine. 45:e208-e210
A 67-year-old asymptomatic man with biochemical recurrent prostate cancer underwent F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. PET/CT images were obtained from the proximal thighs to the vertex of the skull, after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc207ed9adf14dda31e2593602416533
https://doi.org/10.1097/rlu.0000000000002938
https://doi.org/10.1097/rlu.0000000000002938
Publikováno v:
Clinical Nuclear Medicine
A 74-year-old man presenting with biochemical recurrent prostate cancer 9 months after robotic-assisted radical prostatectomy and pelvic lymphadenectomy underwent 18F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. Serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7f26f6040257ff2c5f81f953060d69
https://doi.org/10.1097/rlu.0000000000003844
https://doi.org/10.1097/rlu.0000000000003844
Publikováno v:
Clinical nuclear medicine. 46(4)
A 66-year-old man with prostate adenocarcinoma status post radical retropubic prostatectomy and bilateral pelvic lymph node dissection, followed by salvage external beam radiation therapy to the prostate bed 1 year after surgery. Over the course of 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367d69ee99a316abeb87f82f64b8545d
https://pubmed.ncbi.nlm.nih.gov/33208612
https://pubmed.ncbi.nlm.nih.gov/33208612